| (4-(1-(3-(cyanomethyl)-1-(ethylsulfonyl)azetidin-3-yl)-1H-pyrazol-4-yl)-7H-pyrrolo[2,3-d]pyrimidin-7-yl)methyl pivalate |
巴瑞克替尼中间体3 |
1187595-90-9 |
| Baricitinib phosphate salt |
巴瑞克替尼磷酸盐 |
1187595-84-1 |
| Baricitinib |
巴瑞克替尼 |
1187594-09-7 |
| 2-(1-(ethylsulfonyl)azetidin-3-ylidene)acetonitrile |
2-[1-(乙基磺酰基)-3-氮杂环丁亚基]乙腈 |
1187595-85-2 |
| (1R trans)-2-(3,4-difluorophenyl)cyclopropane amine |
(1R,2S)-REL-2-(3,4-二氟苯基)环丙胺盐酸盐 |
1156491-10-9 |
| 3-Cyclopentyl-3-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazol-1-yl]propanenitrile |
3-环戊基-3-[4-(4,4,5,5-四甲基-1,3,2-二氧杂硼烷-2-基)-1H-吡唑-1-基]丙腈 |
1153949-38-2 |
| (2RS)-2-Cyclohexyl-2-(4-Methoxyphenyl)-N,NdiMethylethanaMineHydrochloride |
盐酸文拉法辛杂质G |
1076199-92-2 |
| GSK1349572 |
度鲁特韦 |
1051375-16-6 |
| Cabotegravir (GSK744, GSK1265744) |
卡博特韦 |
1051375-10-0 |
| ent-montelukast sodium salt |
孟鲁司特EP杂质A |
190078-45-6 |
| 4-methoxy-3-(3-morpholinopropoxy)-2-nitrobenzonitrile |
吉非替尼杂质17 |
1006378-06-8 |
| Ramelteon |
雷美替胺 |
196597-26-9 |
| 11-a-Hydroxy canrenone methyl ester |
11A-羟基坎利酮丙烯酸甲酯 |
192704-56-6 |
| Eplerenone EP Impurity B |
依普利酮EP杂质B |
192704-82-8 |
| Eplerenone intermediate A1 |
Eplerenone intermediate A1 |
192704-54-4 |
| (3S)-N-[[(1S)-1,2,3,4-Tetrahydro-1-naphthalenyl]Methyl]-1-azabicyclo[2.2.2]octan-3-aMine |
(3S)-N-[[(1S)-1,2,3,4-四氢-1-萘基]甲基]-1-氮杂双环[2.2.2]辛烷-3-胺 |
177793-80-5 |
| 3-(Benzyloxy)-5-hydroxybenzoic acid |
3-(苄氧基)-5-羟基苯甲酸 |
159506-17-9 |
| 3-METHYL-8-QUINOLINESULFONIC ACID |
3-甲基-8-喹啉磺酸 |
153886-69-2 |
| SB 204741 |
SB 204741 |
152239-46-8 |
| 2-Butenoicacid,4-(dimethylamino)-,(E)-(9CI) |
(E)-4-(二甲基氨基)丁-2-烯酸 |
149586-32-3 |
QQ
微信
